REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Glaxosmithkline, S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Chemical and Allied Products Merchant Wholesalers
Full name: Glaxosmithkline, S.R.O. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

GlaxoSmithKline Ltd. in the Czech Republic is a subsidiary of one of the largest pharmaceutical companies in the world, GlaxoSmithKline Plc. which is based in London. The company is engaged in research, development, manufacture and marketing of pharmaceuticals and is one of the leading innovators in this field.

Headquarters
Hvezdova 1734/2
Prague; The City of Prague; Postal Code: 14000

Contact Details: Purchase the Glaxosmithkline, S.R.O. report to view the information.

Website: https://cz.gsk.com

Basic Information
Total Employees:
Purchase the Glaxosmithkline, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Glaxosmithkline, S.R.O. report to view the information.
Registered Capital:
Purchase the Glaxosmithkline, S.R.O. report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline, S.R.O. report to view the information.
Incorporation Date:
January 19, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glaxosmithkline, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
11.08%▲
Total operating revenue
11.07%▲
Operating profit (EBIT)
24.09%▲
EBITDA
-19.18%▼
Net Profit (Loss) for the Period
43.57%▲
Total assets
7.58%▲
Total equity
1.87%▲
Operating Profit Margin (ROS)
0.33%▲
Net Profit Margin
0.61%▲
Return on Equity (ROE)
1.76%▲
Quick Ratio
-2.95%▼
Cash Ratio
-0%

Similar companies

Phoenix Lekarensky Velkoobchod, S.R.O.
 
Alliance Healthcare S.R.O.
Zentiva, K.S.
 
Viapharma S.R.O.
Pharmos, A.S.
 
Solvent Cr S.R.O.
B. Braun Medical S.R.O.
 
Astrazeneca Czech Republic S.R.O.
Coty Ceska Republika S.R.O.
 
Walmark, A.S.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo